Table 5.
TLR signaling inhibition by C3 BSC pyrazoles with C5 carboxylic acid derivatives.
![]() | ||||||
|---|---|---|---|---|---|---|
| Cmpd | R5 | IC50 (μM) | ||||
| TLR9 | TLR7 | TLR2 | TLR4 | Tox. | ||
| 53 | CO2Me | 6.29 ± 0.19 | 16.9 ± 0.4 | 15.7 ± 0.5 | > 50 | 30.8 ± 1.3 |
| 54 | CO2H | > 50 | n.d. | n.d. | n.d. | > 50 |
| 55 | CONH2 | 3.43 ± 0.15 | 5.96 ± 0.74 | 27.8 ± 2.5 | > 50 | 17.7 ± 7.7 |
| 56 | CN | 7.89 ± 0.36 | > 50 | > 50 | > 50 | 33.5 ± 3.5 |
| 57 | NH2 | 3.81 ± 0.30 | 5.93 ± 0.04 | > 50 | > 50 | 33.1 ± 3.5 |
| 58 | NHCO2Me | 3.46 ± 0.31 | 3.18 ± 0.21 | > 50 | > 50 | 25.7 ± 5.9 |
| 59 | NHC(O)Me | 3.38 ± 0.14 | 7.25 ± 0.21 | > 50 | 17.4 ± 0.33 | 14.9 ± 2.4 |
| 60 | NHC(O)Et | 2.93 ± 0.84 | 7.92 ± 0.15 | > 50 | > 50 | 38.8 ± 4.5 |
n.d. = not determined
